Company / Operating Income per Share
IGC Pharma, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.09
FY2025
5-year range
-$0.30 / -$0.09
FY2021-FY2025
Trend
+57.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-0.30 to $-0.09 over the past 2 years.
Based on SEC 10-K filings.
-0.09 in FY2025.
Improved from $-0.30 to $-0.09 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 57.8% year-over-year.
- Peak operating income per share was recorded in FY2019.
- Lowest operating income per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -13.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.09 | +57.8% |
| FY2024 | -$0.22 | +27.9% |
| FY2023 | -$0.30 | -65.7% |
| FY2022 | -$0.18 | -4.5% |
| FY2021 | -$0.17 | -48.5% |
| FY2020 | -$0.12 | -102.1% |
| FY2019 | -$0.06 | +20.0% |
| FY2018 | -$0.07 | +41.8% |
| FY2017 | -$0.12 | +96.3% |
| FY2016 | -$3.34 | -71.8% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026